title: [Hyperlipoproteinemia in pregnancy].
abstract: Physiological changes in lipoprotein levels occur in normal pregnancy. Women with hyperlipoproteinemia are advised to discontinue statins, fibrates already when they consider pregnancy up to and including breast-feeding the newborn, because of the fear for teratogenic effects. Hypertriglyceridemia in pregnancy can rarely lead to acute pancreatitis. Management of acute pancreatitis in pregnant women is similar to that used in non-pregnant patients. Further large cohort studies are needed to estimate the consequence of supraphysiologic hyperlipoproteinemia or extreme hyperlipoproteinemia in pregnancy on the risk for cardiovascular disease later in life.
authors.affiliation: Állami Egészségügyi Központ Szakrendelő Intézet Budapest Róbert Károly krt. 44. 1134. drabelt@t-online.hu
authors.forename: Tatjána
authors.initials: T
authors.lastname: Abel
authors.forename: Anna
authors.initials: A
authors.lastname: Blázovics
authors.forename: Márta
authors.initials: M
authors.lastname: Kemény
authors.forename: Gabriella
authors.initials: G
authors.lastname: Lengyel
mesh_terms: D000208:Acute Disease; D000328:Adult; D001942:Breast Feeding; D004334:Drug Administration Schedule; D005260:Female; D058607:Fibric Acids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D015228:Hypertriglyceridemia / Q000175:diagnosis / Q000188:drug therapy; D010195:Pancreatitis / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D013723:Teratogens
chemical_list: D058607:Fibric Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013723:Teratogens